Join the 'Nevirapine' group to help and get support from people like you. How it works
Nevirapine Blog
| Tweet |
FDA Approves Viramune XR (nevirapine) 400 mg extended release tablet
Posted 29 Mar 2011 by Drugs.com
On March 25, 2011, FDA approved Viramune XR (nevirapine) 400 mg extended release tablet. Viramune XR is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults. The approval is based on one principal clinical trial (1100.1486) that demonstrated prolonged suppression of HIV-1 RNA through 48-weeks, and a supportive trial (1100.1526). Additional important information regarding the use of Viramune XR for the treatment of HIV-1 infection: * Based on serious and life-threatening hepatotoxicity observed in controlled and uncontrolled studies, nevirapine should not be initiated in adult females with CD4+ cell counts greater than 250 cells/mm3 or in adult males with CD4+ cell counts greater than 400 cells/mm3 unless the benefit outweighs the risk * The 14-day lead-in period with immediate-release Viramune 200 mg daily dosing must be ... Read more
Related support groups: Nevirapine, Viramune
Many HIV-Exposed Infants in Africa Don't Get Protective Drug, Study Shows
Posted 20 Jul 2010 by Drugs.com
TUESDAY, July 20 – In parts of Africa, only about half of babies born to mothers with HIV receive the HIV prevention drug nevirapine, a new study has found. Researchers looked at mother-infant pairs treated at clinics in Cameroon, Ivory Coast, South Africa and Zambia, and found that only 51 percent of HIV-exposed infants received the minimal dose of nevirapine. The study also found that many HIV-positive women who were prescribed nevirapine before giving birth had no sign of the drug in samples of their umbilical cord blood. "What this study shows us is that there are programmatic failures and common problems that occur along the path to mother-to-child transmission prevention," including patients failing to take medications and inadequacies in HIV testing, study author Dr. Elizabeth Stringer, an associate professor of obstetrics and gynecology at the University of Alabama at ... Read more
Related support groups: HIV Infection, Nevirapine, Viramune
Anti-HIV Drugs May Help Prevent Spread of Virus
Posted 27 May 2010 by Drugs.com
THURSDAY, May 27 – People who are HIV-positive can lower their risk for transmitting the virus to their partners by 90 percent by taking antiretroviral drugs, new research has found. Antiretroviral drug therapy helps reduce HIV levels in the infected person's blood, which in turn makes the person less infectious to others. The drugs are commonly taken in the United States by people with HIV, the virus that causes AIDS. In the new research, published online May 26 in The Lancet, investigators studied more than 3,400 heterosexual couples in seven African countries. In each couple, one person was infected with HIV and the other was not. No one in the study was taking antiretroviral drugs. Health workers counseled the couples about preventing HIV transmission and followed up with them for two years. During that time, periodic blood tests measured HIV levels in the blood, and people were ... Read more
Related support groups: HIV Infection, Atripla, Truvada, Baraclude, Kaletra, Norvir, Hepsera, Combivir, Ritonavir, Lexiva, Viread, Norvir Soft Gelatin, Entecavir, Epivir, Nevirapine
Ask a Question
Further Information
Related Condition Support Groups
HIV Infection, Reduction of Perinatal Transmission of HIV